Cancer Control, Survivorship, and Outcomes Research - total 0.4% / £2,195 Sub-category 6.2: Surveillance - £2,195 In the June 2021 round of the CSO Translational Clinical Studies Committee, the following research project was funded: Developing representative models of the blood-tumour barrier to enhance drug development for Glioblastoma Lead Investigator: Prof.